Heart Failure
Acute heat wave episodes linked to potentially dangerous weight loss in HF
Excessively high temperatures observed during a 2019 heat wave in France were closely associated with weight loss measured in adults with chronic HF, indicating worsening of HF, according to an analysis of telemonitoring and weather data.
Older adults prescribed opioids at elevated risk for CV events, especially HF
Individuals aged 65 years or older who were prescribed opioids had increased risk for various CVD events, most prominently HF, researchers reported in ESC Heart Failure.
Younger age at type 2 diabetes diagnosis linked to higher risk for mortality
Being diagnosed with type 2 diabetes at age 40 years or younger is associated with higher risks for mortality and cardiovascular disease, according to a presenter at the European Association for the Study of Diabetes annual meeting.
Immune checkpoint inhibitor therapy linked to higher incidence of cardiovascular events
Immune checkpoint inhibitor therapy appeared associated with an increased risk for major adverse cardiovascular events among patients with cancer and a prior history of cardiovascular disease, according to results of a retrospective study.
SARS-CoV-2 mRNA vaccines ‘safe to use in heart failure patients’
SARS-CoV-2 vaccination with mRNA vaccines was found to be safe in a large cohort of Danish patients with HF and in turn reduced risk for all-cause death, according to a poster presented at the European Society of Cardiology Congress.
Acetazolamide improves congestion at 3 days in acute decompensated HF
In the ADVOR trial, the addition of IV acetazolamide to standard IV loop diuretics improved acute congestion at 3 days in nearly 50% more patients vs. placebo in the setting of acute decompensated HF and volume overload.
In low-income countries, reduced LVEF common in STEMI, confers poor outcomes
In a cohort of patients with STEMI in India, reduced left ventricular ejection fraction was common and associated with mortality, and medication adherence at 1 year was low, researchers reported.
Major adverse cardiovascular event risk higher with targeted therapies for kidney cancer
Targeted cancer therapy had a higher association with risk for major adverse cardiovascular events than cytokine therapy among patients with advanced renal cell carcinoma, according to study results.
REVEAL-HF: Prognosis information does not impact 1-year outcomes
An embedded electronic health record algorithm that provided HF mortality risk information did not affect clinical decision making about initiation or intensity of treatment or improve outcomes in adults with HF, data show.
Data show HF readmissions after TAVR ‘remain steady’ across centers
A database analysis of hospital readmissions after transcatheter aortic valve replacement show HF readmissions have remained steady over 3 years across low- and high-volume TAVR centers, despite an overall decline in all-cause readmissions.